Research Outputs (16)

Sort by: Date | Title

10 | 25 | 50 | 100

1/2

A B C D E F G H I L M N O P Q R S T U V Z 中促 All

Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging in Late Radiation-Induced Injury of the Brain
CHAN Yu Leung, YEUNG Ka Wai Daivd, LEUNG Sing Fai, LEE Sing Fun Paul, CHING Sik Chung Alex ( 2004 )
12th International Symposium on Intracranial Pressure and Brain Monitoring
Other conference paper
Dual Targeting of MTOR and the microtubule results in marked anti-tumor activity in Hepatocellular Carcinoma (HCC) cells
ZHOU, Qian, LUI Wai Yan Vivian, LAU Pik Yuk Cecilia, YEO Winnie ( 2010 )
5th Sino-US Conference Personalized Medicine in Cancer Therapy in conjunction with the 15th Annual Scientific Symposium of the Hong Kong Cancer Institute
Other conference paper
Drug transporter expressions associate with drug resistance and prognosis in liver cancer patients
Siu Tim Cheung, F.Y. Phyllis Cheung, S.W. Katie Fung, C.N. Charing Chong, L. Stephen Chan, Tan To Cheung, B.S. Paul Lai, G. George Chen, S.W. George Tsao, W.H. Anthony Chan ( 2017 )
Other conference paper
View Full-text in CUHK:
Health Research Symposium 2017 - Durg transporter.pdf
Does severity of underlying chronic liver disease (CLD) affect treatment outcome of hepatocellular carcinoma (HCC) patients undergoing systemic chemotherapy (CT)?
Yeo W, Mo FK, Hui EP, Lam KC, Ho WM, Koh J, Ma B, Mok T, Chan A, Chan SL ( 2009 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion weighted MRI - Scientific Poster Presentation
Ai QY, Chan JSM, Chen W, Chan AKC, Woo JKS, Zee BCY, Chan ATC, Poon DMC, Ma BBY, Hui EP, Ahuja AT, Vlantis AC, King AD ( 2018 )
Other conference paper
Diagnostic Accuracy of Hepatic Angiography With Lipiodol in Hepatocellular Carcinoma
LEUNG Wai Yee Nancy, CHAN Sai Yu Michael, S.M. Ting, LEUNG Wai Tong Thomas, LAU Wan Yee Joseph ( 1992 )
Hellenic Journal of Gastroenterology
Other conference paper
Detection of EGFR-activating mutations from plasma DNA as a potent predictor of survival outcomes in FASTACT 2: A randomized phase III study on intercalated combination of erlotinib (E) and chemotherapy (C).
Mok T, Wu YL, Lee JS, Yu CJ, Sriuranpong V, Wen W, Tsai J, Truman M, Klughammer B, Wu L ( 2013 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
Design of Clinical Trials and Patient's Perception for Traditional Chinese Medicine (TCM)
ZEE Chung Ying Benny, MOK Shu Kam Tony, CHAK Yin Mui Karen, YEO Winnie, LEUNG Sing Fai, CHAN Anthony Tak Cheung ( 2002 )
Workshop on Enhancing the Evidence-base for TCM Practice - Methodology and Grantsmanship
Other conference paper
Design of Clinical Trials and Patients Perception for Traditional Chinese Medicine"
ZEE Chung Ying Benny, MOK Shu Kam Tony, CHAK Yin Mui Karen, YEO Winnie, LEUNG Sing Fai, CHAN Anthony Tak Cheung ( 2004 )
9th Annual Scientific Symposium of the HK Cancer Institute "Anti-Cancer Drug Development - From Bench to Bedside to Market"
Other conference paper
Design of Clinical Trials and Patients Perception for Traditional Chinese Medicine
ZEE Chung Ying Benny, MOK Shu Kam Tony, CHAK Yin Mui Karen, YEO Winnie, LEUNG Sing Fai, CHAN Anthony Tak Cheung ( 2004 )
9th Annual Scientific Symposium of the HK Cancer Institute "Anti-Cancer Drug Development - From Bench to Bedside to Market"
Other conference paper

10 | 25 | 50 | 100

1/2

Research Outputs (16)

Share Link

Our policy towards the use of cookies